NxStage Medical Company Profile (NASDAQ:NXTM)

About NxStage Medical (NASDAQ:NXTM)

NxStage Medical logoNxStage Medical, Inc. is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate preparation equipment and the sale of disposable products in the home and critical care markets. The In-Center segment includes revenues from the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease patients at dialysis clinics, and needles for apheresis. It markets extracorporeal disposable products under the Medisystems brand. The Services segment includes revenues from dialysis services provided to patients at its NxStage Kidney Care dialysis centers. Its product offerings include Home Dialysis, Next-Generation Hemodialysis System, Critical Care, Next-Generation Critical Care System and In-Center.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:NXTM
  • CUSIP: 67072V10
  • Web: www.nxstage.com
  • Market Cap: $1.45 billion
  • Outstanding Shares: 65,735,000
Average Prices:
  • 50 Day Moving Avg: $25.89
  • 200 Day Moving Avg: $26.55
  • 52 Week Range: $18.28 - $30.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 200.55
  • P/E Growth: -36.45
Sales & Book Value:
  • Annual Revenue: $374 million
  • Price / Sales: 3.88
  • Book Value: $3.20 per share
  • Price / Book: 6.89
  • EBIDTA: $14.68 million
  • Net Margins: -1.61%
  • Return on Equity: -2.97%
  • Return on Assets: -1.87%
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 2.97%
  • Quick Ratio: 2.00%
  • Average Volume: 588,568 shs.
  • Beta: 0.37
  • Short Ratio: 7.18

Frequently Asked Questions for NxStage Medical (NASDAQ:NXTM)

What is NxStage Medical's stock symbol?

NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM."

How were NxStage Medical's earnings last quarter?

NxStage Medical, Inc. (NASDAQ:NXTM) issued its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The company had revenue of $96.83 million for the quarter, compared to analyst estimates of $95.31 million. NxStage Medical had a negative net margin of 1.61% and a negative return on equity of 2.97%. NxStage Medical's revenue was up 8.5% compared to the same quarter last year. During the same period last year, the company posted ($0.02) earnings per share. View NxStage Medical's Earnings History.

What guidance has NxStage Medical issued on next quarter's earnings?

NxStage Medical updated its first quarter earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of small loss for the period, compared to the Thomson Reuters consensus estimate of ($0.01). The company issued revenue guidance of $95-97 million, compared to the consensus revenue estimate of $96.08 million.

Where is NxStage Medical's stock going? Where will NxStage Medical's stock price be in 2017?

5 analysts have issued 1 year price targets for NxStage Medical's shares. Their forecasts range from $21.00 to $35.00. On average, they anticipate NxStage Medical's share price to reach $29.60 in the next twelve months. View Analyst Ratings for NxStage Medical.

What are analysts saying about NxStage Medical stock?

Here are some recent quotes from research analysts about NxStage Medical stock:

  • 1. Jefferies Group LLC analysts commented, "Home hemodialysis (HHD) in skilled nursing facilities (SNF) is a significant opportunity for NXTM. HHD penetration is already approaching 6% in the most developed states v. less than 2% for the market as a whole; a disparity explained to a large degree by SNF adoption. The regulatory underpinnings can be debated, but even modest assumptions for continued adoption in SNFs supports 20%+ revenue growth at NXTM. We raise our PT to $38, 5x 2018 sales." (2/6/2017)
  • 2. According to Zacks Investment Research, "NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. " (1/5/2017)

Who are some of NxStage Medical's key competitors?

Who owns NxStage Medical stock?

NxStage Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (11.47%), Vanguard Group Inc. (8.09%), Gilder Gagnon Howe & Co. LLC (7.60%), BlackRock Inc. (6.77%), Eagle Asset Management Inc. (3.12%) and Pennant Capital Management LLC (2.93%). Company insiders that own NxStage Medical stock include Barry M Straube, Craig W Moore, Daniel A Giannini, Earl R Lewis, Jeffrey H Burbank, Joseph E Turk Jr, Joseph E Turk, Jr, Matthew W Towse, Robert S Brown and Winifred L Swan. View Institutional Ownership Trends for NxStage Medical.

Who sold NxStage Medical stock? Who is selling NxStage Medical stock?

NxStage Medical's stock was sold by a variety of institutional investors in the last quarter, including Gilder Gagnon Howe & Co. LLC, Jennison Associates LLC, Cortina Asset Management LLC, Massachusetts Financial Services Co. MA, Wells Fargo & Company MN, William Blair Investment Management LLC, Perceptive Advisors LLC and Prudential Financial Inc.. Company insiders that have sold NxStage Medical stock in the last year include Craig W Moore, Daniel A Giannini, Jeffrey H Burbank, Joseph E Turk Jr, Matthew W Towse, Robert S Brown and Winifred L Swan. View Insider Buying and Selling for NxStage Medical.

Who bought NxStage Medical stock? Who is buying NxStage Medical stock?

NxStage Medical's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Eagle Asset Management Inc., Loomis Sayles & Co. L P, Henderson Group PLC, OppenheimerFunds Inc., Vanguard Group Inc., Nationwide Fund Advisors and Clough Capital Partners L P. Company insiders that have bought NxStage Medical stock in the last two years include Barry M Straube and Earl R Lewis. View Insider Buying and Selling for NxStage Medical.

How do I buy NxStage Medical stock?

Shares of NxStage Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of NxStage Medical stock cost?

One share of NxStage Medical stock can currently be purchased for approximately $22.06.

Analyst Ratings

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $29.60 (34.18% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/10/2017Jefferies Group LLCLower Price TargetBuy$38.00 -> $33.00MediumView Rating Details
5/10/2017BTIG ResearchReiterated RatingBuy$27.00LowView Rating Details
5/8/2017Canaccord GenuityReiterated RatingBuy$32.00HighView Rating Details
5/4/2017Northland SecuritiesDowngradeOutperform -> Market PerformMediumView Rating Details
6/3/2016Piper Jaffray CompaniesReiterated RatingBuy$21.00N/AView Rating Details
5/5/2016Wells Fargo & CoReiterated RatingSellN/AView Rating Details
12/11/2015Sterne Agee CRTInitiated CoverageBuyN/AView Rating Details
11/4/2015Leerink SwannBoost Price Target$24.00 -> $30.00N/AView Rating Details
(Data available from 5/24/2015 forward)


Earnings History for NxStage Medical (NASDAQ:NXTM)
Earnings by Quarter for NxStage Medical (NASDAQ:NXTM)
Earnings History by Quarter for NxStage Medical (NASDAQ:NXTM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.03)($0.02)$95.31 million$96.83 millionViewListenView Earnings Details
2/28/2017Q416($0.02)($0.02)$91.82 million$93.01 millionViewListenView Earnings Details
8/4/2016Q216($0.04)($0.03)$89.44 million$92.20 millionViewN/AView Earnings Details
5/4/2016Q116($0.05)($0.02)$88.40 million$89.20 millionViewListenView Earnings Details
2/10/2016Q415($0.04)($0.04)$86.83 million$89.80 millionViewListenView Earnings Details
11/3/2015Q315($0.08)($0.03)$82.06 million$86.50 millionViewN/AView Earnings Details
8/6/2015Q215($0.10)($0.08)$79.89 million$80.30 millionViewListenView Earnings Details
5/6/2015Q115($0.11)($0.09)$77.92 million$79.50 millionViewListenView Earnings Details
2/26/2015Q414($0.10)($0.08)$75.75 million$79.90 millionViewListenView Earnings Details
11/6/2014Q3($0.13)($0.07)$71.83 million$75.30 millionViewN/AView Earnings Details
8/7/2014Q214($0.11)($0.12)$70.52 million$74.10 millionViewN/AView Earnings Details
5/8/2014Q114($0.11)($0.09)$69.44 million$72.20 millionViewN/AView Earnings Details
2/27/2014Q413($0.09)($0.08)$67.66 million$69.40 millionViewN/AView Earnings Details
11/7/2013Q313$0.22($0.08)$124.03 million$66.90 millionViewListenView Earnings Details
7/25/2013Q2 2013($0.07)($0.06)$64.66 million$65.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013($0.08)($0.08)$61.14 million$61.60 millionViewN/AView Earnings Details
2/28/2013Q4 2012($0.05)($0.04)$63.54 million$65.00 millionViewN/AView Earnings Details
11/8/2012Q312($0.06)($0.04)$60.90 million$61.00 millionViewN/AView Earnings Details
8/8/2012($0.09)($0.09)ViewN/AView Earnings Details
5/8/2012($0.09)($0.09)ViewN/AView Earnings Details
2/29/2012($0.09)($0.08)ViewN/AView Earnings Details
11/3/2011($0.10)($0.10)ViewN/AView Earnings Details
8/3/2011($0.10)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NxStage Medical (NASDAQ:NXTM)
2017 EPS Consensus Estimate: ($0.03)
2018 EPS Consensus Estimate: $0.14
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.03)($0.02)($0.02)
Q2 20173($0.03)$0.00($0.02)
Q3 20173($0.01)$0.01$0.00
Q4 20173$0.00$0.03$0.01
Q1 20182$0.01$0.02$0.02
Q2 20182$0.01$0.04$0.03
Q3 20182$0.03$0.06$0.05
Q4 20182$0.05$0.05$0.05
(Data provided by Zacks Investment Research)


Dividend History for NxStage Medical (NASDAQ:NXTM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for NxStage Medical (NASDAQ:NXTM)
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 97.26%
Insider Trades by Quarter for NxStage Medical (NASDAQ:NXTM)
Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)
Insider Trades by Quarter for NxStage Medical (NASDAQ:NXTM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/22/2017Matthew W TowseSVPSell4,300$21.36$91,848.00View SEC Filing  
5/15/2017Winifred L SwanSVPSell3,500$21.94$76,790.00View SEC Filing  
5/10/2017Joseph E Turk JrPresidentSell250$23.59$5,897.50View SEC Filing  
5/3/2017Joseph E Turk JrPresidentSell1,000$29.95$29,950.00View SEC Filing  
4/20/2017Jeffrey H BurbankCEOSell3,000$27.28$81,840.00View SEC Filing  
4/20/2017Matthew W TowseSVPSell4,300$27.28$117,304.00View SEC Filing  
4/19/2017Jeffrey H BurbankCEOSell3,000$26.65$79,950.00View SEC Filing  
4/13/2017Joseph E Turk JrPresidentSell1,000$26.10$26,100.00View SEC Filing  
4/3/2017Robert S BrownInsiderSell14,397$26.60$382,960.20View SEC Filing  
3/22/2017Jeffrey H BurbankCEOSell3,000$27.42$82,260.00View SEC Filing  
3/21/2017Jeffrey H BurbankCEOSell3,000$27.72$83,160.00View SEC Filing  
3/20/2017Winifred L SwanSVPSell15,723$27.66$434,898.18View SEC Filing  
3/16/2017Craig W MooreDirectorSell1,000$27.93$27,930.00View SEC Filing  
3/8/2017Joseph E Turk JrPresidentSell1,000$27.53$27,530.00View SEC Filing  
3/7/2017Robert S BrownInsiderSell20,000$27.75$555,000.00View SEC Filing  
3/6/2017Robert S BrownInsiderSell6,390$28.01$178,983.90View SEC Filing  
2/23/2017Jeffrey H BurbankCEOSell7,500$28.97$217,275.00View SEC Filing  
2/22/2017Jeffrey H BurbankCEOSell7,500$29.01$217,575.00View SEC Filing  
2/17/2017Joseph E Turk JrPresidentSell6,000$29.66$177,960.00View SEC Filing  
2/15/2017Winifred L SwanSVPSell16,049$28.01$449,532.49View SEC Filing  
2/14/2017Robert S BrownInsiderSell2,448$28.28$69,229.44View SEC Filing  
2/10/2017Joseph E Turk JrPresidentSell3,500$28.36$99,260.00View SEC Filing  
2/8/2017Robert S BrownInsiderSell3,054$27.61$84,320.94View SEC Filing  
2/7/2017Robert S BrownInsiderSell3,117$27.54$85,842.18View SEC Filing  
2/6/2017Robert S BrownInsiderSell16,283$26.87$437,524.21View SEC Filing  
2/2/2017Joseph E Turk JrPresidentSell15,669$26.19$410,371.11View SEC Filing  
2/2/2017Robert S BrownInsiderSell37,347$26.68$996,417.96View SEC Filing  
1/26/2017Robert S BrownInsiderSell42,000$26.05$1,094,100.00View SEC Filing  
1/23/2017Robert S BrownInsiderSell21,615$26.20$566,313.00View SEC Filing  
1/20/2017Matthew W TowseSVPSell4,300$26.19$112,617.00View SEC Filing  
1/18/2017Jeffrey H BurbankCEOSell7,500$27.63$207,225.00View SEC Filing  
1/18/2017Robert S BrownInsiderSell8,183$27.58$225,687.14View SEC Filing  
1/17/2017Jeffrey H BurbankCEOSell7,500$27.52$206,400.00View SEC Filing  
1/17/2017Robert S BrownInsiderSell10,805$27.72$299,514.60View SEC Filing  
1/13/2017Joseph E Turk JrPresidentSell7,500$28.00$210,000.00View SEC Filing  
1/11/2017Joseph E Turk JrPresidentSell1,000$27.77$27,770.00View SEC Filing  
12/20/2016Matthew W TowseSVPSell4,300$25.55$109,865.00View SEC Filing  
12/15/2016Winifred L SwanSVPSell3,500$25.91$90,685.00View SEC Filing  
12/14/2016Jeffrey H BurbankCEOSell7,500$25.68$192,600.00View SEC Filing  
12/13/2016Jeffrey H BurbankCEOSell7,500$25.42$190,650.00View SEC Filing  
12/13/2016Joseph E Turk JrPresidentSell1,000$25.42$25,420.00View SEC Filing  
11/28/2016Joseph E Turk JrPresidentSell12,169$26.01$316,515.69View SEC Filing  
11/23/2016Jeffrey H BurbankCEOSell7,500$24.01$180,075.00View SEC Filing  
11/22/2016Jeffrey H BurbankCEOSell7,500$25.51$191,325.00View SEC Filing  
11/22/2016Winifred L SwanSVPSell3,000$25.51$76,530.00View SEC Filing  
11/21/2016Daniel A GianniniDirectorSell6,449$25.96$167,416.04View SEC Filing  
11/21/2016Matthew W TowseSVPSell4,300$26.23$112,789.00View SEC Filing  
11/17/2016Joseph E Turk JrPresidentSell1,000$25.97$25,970.00View SEC Filing  
11/16/2016Joseph E Turk JrPresidentSell22,500$26.26$590,850.00View SEC Filing  
9/14/2016Craig W MooreDirectorSell3,000$23.31$69,930.00View SEC Filing  
5/12/2016Joseph E Turk JrPresidentSell1,500$17.89$26,835.00View SEC Filing  
5/10/2016Joseph E Turk JrPresidentSell1,057$18.00$19,026.00View SEC Filing  
4/21/2016Joseph E Turk JrPresidentSell2,000$15.73$31,460.00View SEC Filing  
4/14/2016Winifred L SwanSVPSell6,260$16.40$102,664.00View SEC Filing  
4/5/2016Joseph E Turk JrPresidentSell2,500$15.05$37,625.00View SEC Filing  
3/22/2016Joseph E Turk JrPresidentSell2,000$14.34$28,680.00View SEC Filing  
3/14/2016Winifred L SwanSVPSell620$15.69$9,727.80View SEC Filing  
3/10/2016Joseph E Turk JrPresidentSell2,500$15.58$38,950.00View SEC Filing  
2/24/2016Barry M StraubeDirectorBuy1,500$14.20$21,300.00View SEC Filing  
2/24/2016Joseph E Turk JrPresidentSell2,992$14.12$42,247.04View SEC Filing  
2/16/2016Winifred L. SwanSVPSell2,500$14.07$35,175.00View SEC Filing  
2/12/2016Earl R. LewisDirectorBuy21,000$14.63$307,230.00View SEC Filing  
2/10/2016Joseph E. Turk, Jr.PresidentSell991$16.25$16,103.75View SEC Filing  
2/9/2016Joseph E. Turk, Jr.PresidentSell2,500$16.88$42,200.00View SEC Filing  
2/4/2016Joseph E. Turk, Jr.PresidentSell991$19.60$19,423.60View SEC Filing  
1/20/2016Joseph E Turk JrPresidentSell2,000$18.75$37,500.00View SEC Filing  
1/14/2016Winifred L. SwanSVPSell620$19.04$11,804.80View SEC Filing  
1/11/2016Matthew W. TowseSVPSell3,472$20.40$70,828.80View SEC Filing  
1/8/2016Joseph E. Turk, Jr.PresidentSell1,500$21.03$31,545.00View SEC Filing  
1/7/2016Joseph E. Turk, Jr.PresidentSell3,713$20.78$77,156.14View SEC Filing  
12/22/2015Joseph E. Turk, Jr.PresidentSell5,000$20.92$104,600.00View SEC Filing  
12/16/2015Joseph E. Turk, Jr.PresidentSell800$19.99$15,992.00View SEC Filing  
12/15/2015Matthew W. TowseSVPSell2,863$19.51$55,857.13View SEC Filing  
12/14/2015Winifred L. SwanSVPSell2,500$18.90$47,250.00View SEC Filing  
12/10/2015Jeffrey H. BurbankCEOSell9,274$18.94$175,649.56View SEC Filing  
12/8/2015Joseph E. Turk, Jr.PresidentSell2,913$19.38$56,453.94View SEC Filing  
11/20/2015Craig W MooreDirectorSell1,000$20.00$20,000.00View SEC Filing  
11/19/2015Joseph E Turk JrPresidentSell2,000$19.65$39,300.00View SEC Filing  
11/18/2015Craig W MooreDirectorSell4,000$19.60$78,400.00View SEC Filing  
11/16/2015Winifred L. SwanSVPSell2,500$19.65$49,125.00View SEC Filing  
11/12/2015Joseph E. Turk, Jr.PresidentSell4,055$20.44$82,884.20View SEC Filing  
11/10/2015Jeffrey H. BurbankCEOSell10,000$20.75$207,500.00View SEC Filing  
11/10/2015Joseph E. Turk, Jr.PresidentSell7,500$21.03$157,725.00View SEC Filing  
11/10/2015Matthew W. TowseSVPSell2,863$20.32$58,176.16View SEC Filing  
11/9/2015Daniel A GianniniDirectorSell6,593$20.30$133,837.90View SEC Filing  
11/9/2015Jeffrey H. BurbankCEOSell10,000$20.32$203,200.00View SEC Filing  
11/4/2015Joseph E. Turk, Jr.PresidentSell4,826$19.62$94,686.12View SEC Filing  
11/4/2015Matthew W. TowseSVPSell8,591$19.50$167,524.50View SEC Filing  
11/3/2015Robert S. BrowninsiderSell44,400$19.00$843,600.00View SEC Filing  
10/20/2015Joseph E. Turk, Jr.PresidentSell2,000$15.80$31,600.00View SEC Filing  
10/16/2015Jeffrey H. BurbankCEOSell10,000$15.59$155,900.00View SEC Filing  
10/15/2015Jeffrey H. BurbankCEOSell10,000$14.98$149,800.00View SEC Filing  
10/14/2015Winifred L. SwanSVPSell2,500$15.46$38,650.00View SEC Filing  
10/8/2015Joseph E. Turk, Jr.PresidentSell2,839$15.42$43,777.38View SEC Filing  
9/24/2015Joseph E Turk JrPresidentSell2,000$17.26$34,520.00View SEC Filing  
9/17/2015Jeffrey H. BurbankCEOSell10,000$16.18$161,800.00View SEC Filing  
9/16/2015Jeffrey H. BurbankCEOSell10,000$15.99$159,900.00View SEC Filing  
9/15/2015Craig W MooreDirectorSell1,000$16.00$16,000.00View SEC Filing  
9/14/2015Winifred L. SwanSVPSell2,500$16.01$40,025.00View SEC Filing  
9/9/2015Joseph E. Turk, Jr.PresidentSell2,839$16.54$46,957.06View SEC Filing  
8/25/2015Joseph E Turk JrPresidentSell2,000$18.25$36,500.00View SEC Filing  
8/17/2015Robert S BrownInsiderSell10,825$18.30$198,097.50View SEC Filing  
8/14/2015Winifred L SwanSVPSell2,500$18.14$45,350.00View SEC Filing  
8/13/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  
8/12/2015Jeffrey H BurbankCEOSell10,000$18.03$180,300.00View SEC Filing  
8/12/2015Joseph E Turk JrPresidentSell3,252$17.74$57,690.48View SEC Filing  
7/22/2015Joseph E Turk JrPresidentSell2,000$13.86$27,720.00View SEC Filing  
7/14/2015Winifred L SwanSVPSell2,500$14.71$36,775.00View SEC Filing  
6/23/2015Joseph E Turk JrPresidentSell2,000$15.36$30,720.00View SEC Filing  
6/18/2015Jeffrey H BurbankCEOSell20,000$15.56$311,200.00View SEC Filing  
6/15/2015Winifred L SwanSVPSell2,500$15.48$38,700.00View SEC Filing  
6/10/2015Joseph E Turk JrPresidentSell2,839$16.00$45,424.00View SEC Filing  
5/18/2015Winifred L SwanSVPSell2,500$16.65$41,625.00View SEC Filing  
5/12/2015Jeffrey H BurbankCEOSell10,000$16.44$164,400.00View SEC Filing  
4/21/2015Joseph E Turk JrPresidentSell1,950$18.40$35,880.00View SEC Filing  
4/17/2015Jeffrey H BurbankCEOSell10,000$18.08$180,800.00View SEC Filing  
4/16/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  
4/8/2015Joseph E Turk JrPresidentSell1,500$18.34$27,510.00View SEC Filing  
3/26/2015Joseph E Turk JrPresidentSell1,150$16.94$19,481.00View SEC Filing  
3/18/2015Jeffrey H BurbankCEOSell20,000$17.40$348,000.00View SEC Filing  
3/10/2015Joseph E Turk JrPresidentSell1,500$16.44$24,660.00View SEC Filing  
2/25/2015Joseph E Turk JrPresidentSell2,082$17.88$37,226.16View SEC Filing  
1/27/2015Joseph E Turk JrPresidentSell2,350$18.70$43,945.00View SEC Filing  
1/14/2015Winifred L SwanSVPSell500$18.44$9,220.00View SEC Filing  
1/13/2015Joseph E Turk JrPresidentSell1,500$18.35$27,525.00View SEC Filing  
1/13/2015Winifred L SwanSVPSell666$18.35$12,221.10View SEC Filing  
12/29/2014Winifred L SwanSVPSell667$18.17$12,119.39View SEC Filing  
12/23/2014Joseph E Turk JrPresidentSell2,350$18.44$43,334.00View SEC Filing  
12/15/2014Joseph E Turk JrPresidentSell2,000$17.45$34,900.00View SEC Filing  
12/15/2014Kevin HershbergerCAOSell8,000$17.19$137,520.00View SEC Filing  
12/10/2014Joseph E Turk JrPresidentSell1,500$17.77$26,655.00View SEC Filing  
12/5/2014Jeffrey H BurbankCEOSell5,000$17.16$85,800.00View SEC Filing  
12/2/2014Robert S BrownInsiderSell34,700$17.44$605,168.00View SEC Filing  
12/1/2014Joseph E Turk JrPresidentSell24,762$17.04$421,944.48View SEC Filing  
12/1/2014Winifred L SwanSVPSell16,667$17.04$284,005.68View SEC Filing  
11/25/2014Joseph E Turk JrPresidentSell3,350$17.59$58,926.50View SEC Filing  
11/14/2014Joseph E Turk JrPresidentSell29,560$17.39$514,048.40View SEC Filing  
11/14/2014Winifred L SwanSVPSell17,167$17.37$298,190.79View SEC Filing  
11/12/2014Joseph E Turk JrPresidentSell26,261$16.27$427,266.47View SEC Filing  
11/12/2014Kevin HershbergerCAOSell11,056$16.58$183,308.48View SEC Filing  
11/7/2014Joseph E Turk JrPresidentSell24,761$16.25$402,366.25View SEC Filing  
11/3/2014Joseph E Turk JrPresidentSell5,717$15.50$88,613.50View SEC Filing  
10/23/2014Joseph E Turk JrPresidentSell3,550$14.55$51,652.50View SEC Filing  
10/23/2014Robert S BrownInsiderSell45,370$14.53$659,226.10View SEC Filing  
9/24/2014Joseph E Turk JrPresidentSell3,550$13.34$47,357.00View SEC Filing  
9/19/2014Jeffrey H BurbankCEOSell2,416$14.00$33,824.00View SEC Filing  
9/19/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
9/10/2014Kevin HershbergerCAOSell843$13.58$11,447.94View SEC Filing  
9/8/2014Jeffrey H BurbankCEOSell2,322$14.00$32,508.00View SEC Filing  
9/8/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
8/27/2014Joseph E Turk JrPresidentSell2,550$13.06$33,303.00View SEC Filing  
8/15/2014Winifred L SwanSVPSell2,500$13.60$34,000.00View SEC Filing  
8/7/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
8/7/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
7/24/2014Joseph E Turk JrPresidentSell3,550$13.50$47,925.00View SEC Filing  
7/18/2014Winifred L SwanSVPSell2,000$13.46$26,920.00View SEC Filing  
6/24/2014Joseph E Turk JrPresidentSell3,950$14.43$56,998.50View SEC Filing  
6/20/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
6/17/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
6/9/2014Winifred L SwanSVPSell9,228$14.00$129,192.00View SEC Filing  
6/5/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
6/5/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
6/5/2014Winifred L SwanSVPSell7,500$14.00$105,000.00View SEC Filing  
5/29/2014Joseph E Turk JrPresidentSell4,035$13.60$54,876.00View SEC Filing  
5/15/2014Winifred SwanSVPSell9,629$12.80$123,251.20View SEC Filing  
5/14/2014Winifred SwanSVPSell5,000$13.04$65,200.00View SEC Filing  
3/6/2014Robert FunariDirectorBuy10,150$14.72$149,408.00View SEC Filing  
10/21/2013Robert S BrownInsiderSell140,100$14.00$1,961,400.00View SEC Filing  
9/9/2013Thomas SheaSVPSell1,000$12.30$12,300.00View SEC Filing  
8/12/2013Thomas SheaSVPSell1,172$12.93$15,153.96View SEC Filing  
7/8/2013Thomas SheaSVPSell7,000$14.34$100,380.00View SEC Filing  
6/10/2013Thomas SheaSVPSell5,000$13.73$68,650.00View SEC Filing  
5/13/2013Thomas SheaSVPSell15,724$12.67$199,223.08View SEC Filing  
11/13/2012David S UtterbergDirectorSell184,204$11.58$2,133,082.32View SEC Filing  
11/2/2012David S UtterbergDirectorSell34,730$11.13$386,544.90View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for NxStage Medical (NASDAQ:NXTM)
Latest Headlines for NxStage Medical (NASDAQ:NXTM)
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) SVP Sells $91,848.00 in Stock
www.americanbankingnews.com - May 23 at 8:18 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 22 at 4:04 PM
bizjournals.com logoResearch Reports Initiation on Medical Equipment Stocks -- Masimo, NovoCure, Nxstage Medical, and Varex Imaging
www.bizjournals.com - May 22 at 9:48 AM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) SVP Sells $76,790.00 in Stock
www.americanbankingnews.com - May 15 at 8:21 PM
finance.yahoo.com logoEdited Transcript of NXTM earnings conference call or presentation 9-May-17 1:00pm GMT
finance.yahoo.com - May 15 at 10:03 AM
americanbankingnews.com logo$96.7 Million in Sales Expected for NxStage Medical, Inc. (NXTM) This Quarter
www.americanbankingnews.com - May 13 at 9:40 AM
americanbankingnews.com logoLeerink Swann Research Analysts Lower Earnings Estimates for NxStage Medical, Inc. (NXTM)
www.americanbankingnews.com - May 12 at 12:32 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Expected to Earn Q2 2017 Earnings of ($0.03) Per Share
www.americanbankingnews.com - May 12 at 8:51 AM
americanbankingnews.com logoQ2 2017 EPS Estimates for NxStage Medical, Inc. (NXTM) Reduced by William Blair
www.americanbankingnews.com - May 12 at 8:50 AM
americanbankingnews.com logoQ2 2018 EPS Estimates for NxStage Medical, Inc. (NXTM) Cut by Analyst
www.americanbankingnews.com - May 11 at 2:14 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Expected to Post Q3 2017 Earnings of ($0.01) Per Share
www.americanbankingnews.com - May 11 at 9:52 AM
americanbankingnews.com logoQ3 2017 EPS Estimates for NxStage Medical, Inc. (NXTM) Cut by Analyst
www.americanbankingnews.com - May 11 at 9:52 AM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Expected to Announce Earnings of -$0.01 Per Share
www.americanbankingnews.com - May 11 at 8:20 AM
streetinsider.com logoNxstage Medical (NXTM) Reports FDA Clearance for iNew System One Hemodialysis System - StreetInsider.com
www.streetinsider.com - May 11 at 12:11 AM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Stock Rating Reaffirmed by Jefferies Group LLC
www.americanbankingnews.com - May 10 at 7:36 PM
streetinsider.com logoNxstage Medical (NXTM) Reports FDA Clearance for iNew System One Hemodialysis System
www.streetinsider.com - May 10 at 7:09 PM
finance.yahoo.com logoNxStage Medical Announces FDA Clearance for its New System One Hemodialysis System
finance.yahoo.com - May 10 at 7:09 PM
americanbankingnews.com logoBTIG Research Reaffirms Buy Rating for NxStage Medical, Inc. (NXTM)
www.americanbankingnews.com - May 10 at 7:38 AM
nasdaq.com logoNxStage Medical Becomes Oversold (NXTM)
www.nasdaq.com - May 9 at 6:36 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Posts Earnings Results, Hits Estimates
www.americanbankingnews.com - May 9 at 3:44 PM
fool.com logoWhy NxStage Medical, Inc. Got Hammered Today
www.fool.com - May 9 at 2:04 PM
streetinsider.com logoForm 8-K NxStage Medical, Inc. For: May 09
www.streetinsider.com - May 9 at 11:25 AM
finance.yahoo.com logoNxStage Reports First Quarter Financial Results
finance.yahoo.com - May 9 at 11:25 AM
finance.yahoo.com logoNxStage reports 1Q loss
finance.yahoo.com - May 9 at 11:25 AM
finance.yahoo.com logoInvestor Network: NxStage Medical, Inc. to Host Earnings Call
finance.yahoo.com - May 9 at 11:25 AM
finance.yahoo.com logoNxStage Medical Cuts Its Home Sales Outlook
finance.yahoo.com - May 9 at 11:25 AM
americanbankingnews.com logoNxStage Medical's (NXTM) "Buy" Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - May 8 at 9:36 PM
americanbankingnews.com logoInsider Selling: NxStage Medical, Inc. (NXTM) President Sells 1,000 Shares of Stock
www.americanbankingnews.com - May 5 at 9:40 AM
nasdaq.com logoAthena Capital Advisors Llc Buys First Midwest Bancorp Inc, Berkshire Hathaway Inc, Cohen & ...
www.nasdaq.com - May 4 at 7:07 PM
finance.yahoo.com logoNxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : May 4, 2017
finance.yahoo.com - May 4 at 7:07 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Rating Lowered to Market Perform at Northland Securities
www.americanbankingnews.com - May 4 at 3:14 PM
finance.yahoo.com logoWhy Nxstage Medical, Inc. Slumped Today
finance.yahoo.com - May 3 at 8:06 PM
americanbankingnews.com logoNxStage Medical (NXTM) Earns Daily Media Sentiment Score of 0.37
www.americanbankingnews.com - May 3 at 6:52 PM
americanbankingnews.com logoFavorable News Coverage Very Likely to Impact NxStage Medical (NXTM) Stock Price
www.americanbankingnews.com - April 29 at 12:20 AM
americanbankingnews.com logoNxStage Medical (NXTM) Receives Media Sentiment Rating of 0.22
www.americanbankingnews.com - April 25 at 8:02 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 25 at 4:28 PM
finance.yahoo.com logoNxStage Medical, Inc. – Value Analysis (NASDAQ:NXTM) : April 24, 2017
finance.yahoo.com - April 24 at 7:18 PM
americanbankingnews.com logo$95.34 Million in Sales Expected for NxStage Medical, Inc. (NXTM) This Quarter
www.americanbankingnews.com - April 22 at 9:33 AM
americanbankingnews.com logoNxStage Medical (NXTM) Earns Media Impact Rating of 0.18
www.americanbankingnews.com - April 22 at 12:59 AM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) CEO Jeffrey H. Burbank Sells 3,000 Shares
www.americanbankingnews.com - April 21 at 9:08 PM
finance.yahoo.com logoNxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : April 21, 2017
finance.yahoo.com - April 21 at 9:20 AM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) SVP Matthew W. Towse Sells 4,300 Shares
www.americanbankingnews.com - April 20 at 8:09 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) CEO Sells $79,950.00 in Stock
www.americanbankingnews.com - April 20 at 8:09 PM
americanbankingnews.com logoNxStage Medical, Inc. (NXTM) Expected to Post Earnings of -$0.03 Per Share
www.americanbankingnews.com - April 20 at 9:05 AM
americanbankingnews.com logoNxStage Medical (NXTM) Getting Positive Press Coverage, Analysis Shows
www.americanbankingnews.com - April 18 at 5:28 PM
americanbankingnews.com logoNxStage Medical (NXTM) Earning Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 15 at 4:51 PM
americanbankingnews.com logoJoseph E. Turk, Jr. Sells 1,000 Shares of NxStage Medical, Inc. (NXTM) Stock
www.americanbankingnews.com - April 14 at 7:40 PM
prnewswire.com logoTechnical Reports on Medical Equipment Equities -- ViewRay, Avinger, Nxstage, and Natus - PR Newswire (press release)
www.prnewswire.com - April 13 at 8:04 AM
finance.yahoo.com logoNxStage® to Report First Quarter 2017 Financial Results
finance.yahoo.com - April 7 at 11:39 AM
americanbankingnews.com logoRobert S. Brown Sells 14,397 Shares of NxStage Medical, Inc. (NXTM) Stock
www.americanbankingnews.com - April 4 at 8:37 PM



NxStage Medical (NXTM) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by MarketBeat.com Staff